Dr. Ohad Karnieli contributes a wealth of knowledge and experience in cell and gene therapy to the team at Cell One Partners. As the Founder and CEO of Adva Biotechnology, he developed an innovative platform that allows simple, automated, and highly controlled Cell Therapy manufacturing. Prior to Adva Biotechnology, Dr Karnieli established a leading innovation center for cell and gene therapy called Atvio Biotech, which was later sold to Orgenesis Inc. His leadership at Atvio Biotech underscores his ability to drive innovation and growth in the biotech sector. Dr. Karnieli's role as VP of Technology & Manufacturing at Pluristem Therapeutics further highlights his expertise, where he led process development, product development, and GMP manufacturing. During his five-year tenure at Pluristem, he was responsible for designing, building, and operating the company's state-of-the-art automatic cell therapy manufacturing facility, showcasing his proficiency in advanced manufacturing technologies.

​

In addition to his accomplishments at Adva Biotechnology, Atvio Biotech, and Pluristem Therapeutics, Dr. Karnieli served as VP of Medical Devices at Goji Solutions, where he focused on developing innovative RF-based medical devices. His diverse experience in both the biotech and medical device industries demonstrates his versatility and comprehensive understanding of the field. Dr. Karnieli's contributions to the development and commercialization of cutting-edge therapies and technologies make him a valuable asset to any team focused on advancing cell and gene therapy.